Trials / Completed
CompletedNCT00704769
Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)
Observational Study Evaluating the Safety and Efficacy of Desloratadine Syrup for Perennial Allergic Rhinitis in Indonesian Pediatric Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 591 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 2 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the safety and general clinical response of desloratadine syrup in the relief of symptoms associated with perennial allergic rhinitis in Indonesian pediatric patients.
Detailed description
Children, ages 2-11, with a history of perennial allergic rhinitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desloratadine (assigned by investigator as part of normal practice) | Desloratadine syrup, 2.5 mL (1.25mg) once daily for 2-5 year olds, 5 mL (2.5mg) once daily for 6-11 year olds, minimum 7 days of treatment, minimum of 2 visits |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2008-06-25
- Last updated
- 2022-02-09
- Results posted
- 2009-08-11
Source: ClinicalTrials.gov record NCT00704769. Inclusion in this directory is not an endorsement.